华法林,PubMed 中的摘要说明，变体和药物之间的可能关系

华法林

化学ID

PA451906

化学名称(英)

warfarin

书本上化学名称

华法林

书本上化学名称(英)

warfarin

变体ID

PA165816544

变体名称

CYP2C9*3

变体类型

单倍型

变体类型(英)

Haplotype

变体名称文本

* 3

基因身份证

PA126

基因符号

CYP2C9

基因文本

文学ID

PMID

30962704

文献标题

Impact of a variable number tandem repeat in the CYP2C9 promoter on warfarin sensitivity and responsiveness in Jordanians with cardiovascular disease

出版年

2019

杂志

Pharmacogenomics and Personalized Medicine

句子

In the late 2000s, the United States Food and Drug Administration announced that the warfarin label stat (which describes patients' therapeutic dosage) had to underline its pharmacogenetic activity, particularly in patients with VKORC1 1, 639G>A, CYP2C9 * 2, and CYP2C9 * 3 polymorphisms.

源

PGxMine